← SynDRA
XMD-885
SynDRA canonical compound SYN0086819 — structure-anchored drug synonym record
| Primary target(s) | MAPK7 |
| Mechanism of action | Leucine rich repeat kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- MEK inhibitor
- Leucine rich repeat kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- ALOX15
- TP53
- TDP1
- SMN1
- SMAD3
- PIN1
- NPSR1
- NPC1
- MAPT
- LMNA
- IDH1
- HTT
- HPGD
- HDAC6
- GMNN
- GLP1R
- GBA1
- EHMT2
- CGA
- ATXN2
- ATAD5
- APOBEC3G
- APOBEC3F
- APEX1
- USP2
Cross-references
Synonyms
- XMD8-85
- SCHEMBL618262
- orb1302017
- SCHEMBL29360090
- SCHEMBL31092834
- CHEBI:91375
- C25H29N7O2
- HMS3295A11
- EX-A3073
- JZB47976
- BDBM50337127
- ZB1553
- ERK5-IN-1 XMD 8-85
- AKOS030526340
- CS-4938
- EBC-521728
- XMD17-109 (ERK5-IN-1)
- AC-36310
- BS-14786
- HY-14403
- T5184
- D71039
- BRD-K64857848-001-01-5
- BRD-K64857848-001-06-4
- X7Y
- 2-[2-methoxy-4-(4-methyl-1-piperazinyl)anilino]-5,11-dimethyl-6-pyrimido[4,5-b][1,4]benzodiazepinone
Look up XMD-885 in the interactive SynDRA portal →